Huadong Medicine Co., Ltd

SZSE:000963 Stock Report

Market Cap: CN¥62.9b

Huadong Medicine Future Growth

Future criteria checks 1/6

Huadong Medicine is forecast to grow earnings and revenue by 13.2% and 7.9% per annum respectively. EPS is expected to grow by 13.1% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

13.2%

Earnings growth rate

13.1%

EPS growth rate

Healthcare earnings growth22.9%
Revenue growth rate7.9%
Future return on equity16.8%
Analyst coverage

Good

Last updated11 Dec 2024

Recent future growth updates

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 49% Undervalued

Dec 16
An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 49% Undervalued

We Think Huadong Medicine (SZSE:000963) Can Stay On Top Of Its Debt

Nov 29
We Think Huadong Medicine (SZSE:000963) Can Stay On Top Of Its Debt

Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Nov 13
Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Sep 23
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Aug 05
Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

Jun 28
Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Jun 10
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Apr 08
Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Is Huadong Medicine (SZSE:000963) A Risky Investment?

Mar 16
Is Huadong Medicine (SZSE:000963) A Risky Investment?

Earnings and Revenue Growth Forecasts

SZSE:000963 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202650,2594,2823,2404,78612
12/31/202546,8333,9122,7214,23014
12/31/202443,2363,2932,6153,94214
9/30/202441,7073,2122,6094,186N/A
6/30/202441,2043,1012,5164,183N/A
3/31/202440,9202,9462,0103,691N/A
12/31/202340,6242,8392,3233,929N/A
9/30/202340,2512,7071,9963,311N/A
6/30/202339,9022,5922,9324,119N/A
3/31/202338,8972,5509982,396N/A
1/1/202337,7152,4991,1892,382N/A
9/30/202236,4942,3881,2662,384N/A
6/30/202235,5822,3426961,715N/A
3/31/202234,5992,2481,8972,607N/A
1/1/202234,5632,3022,3513,170N/A
9/30/202134,1102,3242,4683,616N/A
6/30/202134,2022,3892,5403,894N/A
3/31/202133,9822,4311,9863,495N/A
12/31/202033,6832,8201,9383,411N/A
9/30/202033,3192,9911,6692,994N/A
6/30/202033,8582,9481,0362,294N/A
3/31/202034,3393,0531,3452,654N/A
12/31/201935,4462,8136482,002N/A
9/30/201935,0872,6714691,537N/A
6/30/201933,5872,5708781,932N/A
3/31/201932,5322,5151,2252,163N/A
12/31/201830,6632,2671,1632,039N/A
9/30/201829,5852,0992,2152,946N/A
6/30/201829,0662,031N/A2,455N/A
3/31/201828,5191,895N/A1,985N/A
12/31/201727,8321,780N/A1,661N/A
9/30/201727,9111,740N/A1,009N/A
6/30/201727,2271,665N/A612N/A
3/31/201726,3631,556N/A1,085N/A
12/31/201625,3801,447N/A1,347N/A
9/30/201624,4911,365N/A957N/A
6/30/201623,5881,253N/A796N/A
3/31/201622,6821,188N/A387N/A
12/31/201521,7271,097N/A659N/A
9/30/201520,9231,136N/A545N/A
6/30/201520,2201,034N/A1,144N/A
3/31/201519,656899N/A857N/A
12/31/201418,947757N/A741N/A
9/30/201418,208655N/A1,349N/A
6/30/201417,724631N/A624N/A
3/31/201417,237617N/A395N/A
12/31/201316,718575N/A477N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000963's forecast earnings growth (13.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 000963's earnings (13.2% per year) are forecast to grow slower than the CN market (25.7% per year).

High Growth Earnings: 000963's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000963's revenue (7.9% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 000963's revenue (7.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000963's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 23:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huadong Medicine Co., Ltd is covered by 38 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Changming HeBOCI Research Ltd.
Ethan CuiBofA Global Research
Shuchang LiuChangjiang Securities Co. LTD.